- Trials with a EudraCT protocol (566)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (53)
566 result(s) found for: Dialysis.
Displaying page 1 of 29.
EudraCT Number: 2009-011505-16 | Sponsor Protocol Number: 3.0 | Start Date*: 2010-01-21 | |||||||||||
Sponsor Name:Medizinische Universität Wien,KIM I,Klinische Abteilung für Infektionen u.Tropenmedizin | |||||||||||||
Full Title: Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis | |||||||||||||
Medical condition: A total of 8 patients with renal insufficiency and treatment with automated peritoneal dialysis (APD) will be enrolled into this study evaluating the pharmacokinetics of fosfomycin in this special ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024449-65 | Sponsor Protocol Number: 159:2010/526806 | Start Date*: 2011-02-22 | |||||||||||
Sponsor Name:Västerbottens läns landsting | |||||||||||||
Full Title: Will there be lipid changes during dialysis with Citrasate as dialysate compared to conventional dialysis. | |||||||||||||
Medical condition: Chronic haemodialysis patients 18 years upwards. Patients should be in a stable condition during their chronic dialysis program (no ongoing infections or active extensive tumour with CRP above 30 m... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006965-18 | Sponsor Protocol Number: AGO/2006/13 | Start Date*: 2007-02-20 | |||||||||||
Sponsor Name:University Hospital Ghent | |||||||||||||
Full Title: Acute hemodynamische impact van een intraveneuze glucose injectie | |||||||||||||
Medical condition: Peritoneale Dialyse | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003867-76 | Sponsor Protocol Number: RRK4249 | Start Date*: 2013-11-07 | |||||||||||||||||||||||||||||||
Sponsor Name:University Hospitals Birmingham NHS Foundation Trust | |||||||||||||||||||||||||||||||||
Full Title: A prospective, randomised controlled trial to determine the safety and efficacy of steroid impregnated tape compared to standard therapy with silver nitrate in the treatment of over-granulating per... | |||||||||||||||||||||||||||||||||
Medical condition: Over-granulation of peritoneal dialysis exit site in patients with End Stage Renal Failure | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000765-37 | Sponsor Protocol Number: P-CKD-01 | Start Date*: 2007-05-10 | |||||||||||||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||||||||||||
Full Title: A non-comparative open-label study of Iron Oligosaccharide in Chronic Kidney Disease patients with a need for parenteral iron | |||||||||||||||||||||||
Medical condition: Patients with Chronic kidney disease who are in pre-dialysis or undergoing dialysis (either Peritoneal Dialysis or Haemodialysis), who may be treated with erythropoeisis stimulating agents and have... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: SE (Completed) DK (Completed) GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021665-68 | Sponsor Protocol Number: Citrasate01 | Start Date*: 2010-10-06 | ||||||||||||||||
Sponsor Name:University Hospital Antwerp | ||||||||||||||||||
Full Title: Comparison of Slow Efficiency dialysis (SLEDD) with Unfractionated Heparin versus Citrasate in Critically Ill Patients | ||||||||||||||||||
Medical condition: To compare the feasability, safety and efficacy of Sustained Slow Efficiency Dialys (SLEDD) using regional anticoagulation with Citrasate compared to systemic anticoagulation with Unfractionated He... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004004-36 | Sponsor Protocol Number: ZP-PDProtec-102 | Start Date*: 2013-01-14 |
Sponsor Name:Med. Univ. Wien, UK für Kinder und Jugendheilkunde | ||
Full Title: Pilot Study to define the Feasibility of ex-vivo LPS stimulated Cytokine release for Testing Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solutions in Peritoneal Dialysis (PD) | ||
Medical condition: Peritoneal dialysis is a process of removing metabolic waste products and excess water from the patient's body, replacing the function of the diseased kidneys. Currently, despite the clear benef... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006928-18 | Sponsor Protocol Number: 06/Q0603/57 | Start Date*: 2007-04-25 | |||||||||||
Sponsor Name:Barts and The London NHS Trust | |||||||||||||
Full Title: Randomised trial of Prontosan wound gel for prevention of exit site infection in peritoneal dialysis patients | |||||||||||||
Medical condition: Peritoneal dialysis patients and their peritoneal dialysis catheter exit site care. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003406-28 | Sponsor Protocol Number: LF AMB AD | Start Date*: 2005-09-07 |
Sponsor Name:Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine | ||
Full Title: Pharmakokinetik von lipid-formuliertem Amphotericin B unter Albumindialyse (Pharmacokinetics of lipid-formulated amphotericin B during albumin dialysis) | ||
Medical condition: Plasma concentrations of lipidformulated amphotericin B will be measured in patients requiring treatment with lipid-formulated amphotericin B for systemic fungal infection (proven or suspected) an... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002488-40 | Sponsor Protocol Number: LIPMAT | Start Date*: 2015-11-06 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: The LIPMAT study: Liposomal prednisolone to improve hemodialysis fistula maturation | |||||||||||||
Medical condition: Nonmaturation of arteriovenous vascular accesses for hemodialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001257-51 | Sponsor Protocol Number: 220322020 | Start Date*: 2020-04-15 | |||||||||||||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||||||||||||
Full Title: The Danish Pre-HCQ Dialysis Study: Hydroxychloroquine for prevention of COVID-19 in dialysis-treated patients with end-stage renal disease - A multicenter parallel-group open randomized clinical... | |||||||||||||||||||||||
Medical condition: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004360-23 | Sponsor Protocol Number: P-03-235 | Start Date*: 2006-07-03 |
Sponsor Name:Barts and The London NHS Trust | ||
Full Title: Randomised controlled study of “physiological” peritoneal dialysis solutions. | ||
Medical condition: End stage renal failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003078-33 | Sponsor Protocol Number: QRK306 | Start Date*: 2016-04-13 | |||||||||||
Sponsor Name:Quark Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death ... | |||||||||||||
Medical condition: QPI-1002 is being developed for the prevention of Delayed Graft Function in patients receiving renal transplants. The patient population of the current study will include patients undergoing deceas... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) BE (Completed) NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002984-23 | Sponsor Protocol Number: 33-391ex20/21 | Start Date*: 2021-08-01 |
Sponsor Name:Medical University of Graz | ||
Full Title: Retrospective quantification of anti-SARS-CoV-2 antibody response after mRNA COVID-19 vaccine in patients treated with peritoneal dialysis | ||
Medical condition: Chronic peritoneal dialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002174-32 | Sponsor Protocol Number: REN00304 | Start Date*: 2005-01-13 | |||||||||||
Sponsor Name:Genzyme Europe BV | |||||||||||||
Full Title: An open label, randomized, parallel design study to investigate the efficacy and safety of sevelamer hydrochloride (Renagel®) compared with calcium acetate in peritoneal dialysis patients (REN00304) | |||||||||||||
Medical condition: Peritoneal dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001520-18 | Sponsor Protocol Number: NL76839.042.21 | Start Date*: 2021-04-09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:RECOVAC consortium | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Long term efficacy and safety of SARS-CoV-2 vaccination in Dutch patients with chronic kidney disease stage G4-G5, on dialysis or after kidney transplantation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: COVID-19 is associated with increased morbidity and mortality in kidney transplant recipients (KTR) and patients with chronic kidneydisease (CKD). Therefore, potential efficacious SARS-CoV-2 vaccin... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004053-10 | Sponsor Protocol Number: HN014/HBV-001 | Start Date*: 2006-02-02 |
Sponsor Name:Henogen | ||
Full Title: A phase III, multicentric, multinational, controlled, randomised, open study comparing the immunogenicity, reactogenicity and safety of Henogen’s new adjuvanted hepatitis B vaccine, HB-AS02V, admin... | ||
Medical condition: hepatitis B naïve pre-dialysis, peritoneal dialysis and haemodialysis patients from 15 years of age | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) CZ (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005274-30 | Sponsor Protocol Number: UCL_2011_DIDo | Start Date*: 2012-08-27 | |||||||||||
Sponsor Name:Université catholique de Louvain | |||||||||||||
Full Title: Efficacy and safety of a Double Icodextrin Dose in elderly incident CAPD patients on incremental Peritoneal Dialysis therapy: the DIDo study | |||||||||||||
Medical condition: Patients with chronic renal failure who are starting a Continuous Ambulatory Peritoneal Dialysis (CAPD) as first line dialyse. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002338-39 | Sponsor Protocol Number: 17 | Start Date*: 2006-12-22 |
Sponsor Name:Universitätsklinikum Heidelberg | ||
Full Title: Pharmakokinetik von Linezolid bei Dialyse (pharmacokinetics of linezolid under dialysis) | ||
Medical condition: acute renal failure and infection or sepsis without acute renal failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004608-21 | Sponsor Protocol Number: 20170724 | Start Date*: 2019-07-30 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: Phase 3, Single-arm, Open-label, Multidose, Titration, Pharmacokinetic, Pharmacodynamic, and Safety Study of Etelcalcetide in Children and Adolescents ≥ 2 to < 18 Years of age With Secondary Hyperp... | |||||||||||||
Medical condition: Secondary Hyperparathyroidism (sHPT) Receiving Maintenance Haemodialysis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) GR (Trial now transitioned) DE (Ongoing) CZ (Trial now transitioned) PT (Ongoing) HU (Ongoing) FR (Completed) PL (Trial now transitioned) LT (Completed) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.